Homocysteine-related hTERT DNA demethylation contributes toshortened leukocyte telomere length in atherosclerosis

Atherosclerosis

Volumn 231, Issue 1, 2013, Pages 173-179

  Zhang, Donghong ^a   Wen, Xuemei ^a   Wu, Wei ^a   Xu, Ermu ^a   Zhang, Yujuan ^a   Cui, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Atherosclerosis; DNA methyaltion; Homocysteine; HTERT; Leukocyte; Telomere length

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYANOCOBALAMIN; DNA; FOLIC ACID; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; TRIACYLGLYCEROL;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; DEMETHYLATION; DNA METHYLATION; FEMALE; FOLIC ACID BLOOD LEVEL; GENE EXPRESSION; HUMAN; HYPERHOMOCYSTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE SHORTENING; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ATHEROSCLEROSIS; DNA METHYALTION; HOMOCYSTEINE; HTERT; LEUKOCYTE; TELOMERE LENGTH;

ANIMALS; ATHEROSCLEROSIS; EPIGENESIS, GENETIC; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LEUKOCYTES; MICE; TELOMERASE; TELOMERE; TELOMERE SHORTENING;

EID: 84885399790     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.08.029     Document Type: Article

References (36)

1. Fyhrquist F., Saijonmaa O., Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol 2013, 10:274-283.
2. Panayiotou A.G., Nicolaides A.N., Griffin M., et al. Leukocyte telomere length is associated with measures of subclinical atherosclerosis. Atherosclerosis 2010, 211:176-181.
3. Richards J.B., Valdes A.M., Gardner J.P., et al. Homocysteine levels and leukocyte telomere length. Atherosclerosis 2008, 200:271-277.
4. Vasan R.S., Demissie S., Kimura M., et al. Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation 2008, 117:1138-1144.
5. Diaz V.A., Mainous A.R., Everett C.J., Schoepf U.J., Codd V., Samani N.J. Effect of healthy lifestyle behaviors on the association between leukocyte telomere length and coronary artery calcium. Am J Cardiol 2010, 106:659-663.
6. Fitzpatrick A.L., Kronmal R.A., Kimura M., et al. Leukocyte telomere length and mortality in the Cardiovascular Health Study. JGerontol A Biol Sci Med Sci 2011, 66:421-429.
7. Diez R.A., Ranjit N., Jenny N.S., et al. Race/ethnicity and telomere length in the Multi-Ethnic Study of atherosclerosis. Aging Cell 2009, 8:251-257.
8. Vogel G., Pennisi E. Physiology nobel. U.S. researchers recognized for work on telomeres. Science 2009, 326:212-213.
9. Kyo S., Takakura M., Fujiwara T., Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 2008, 99:1528-1538.
10. Choi J.H., Min N.Y., Park J., et al. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. Biochem Biophys Res Commun 2010, 391:449-454.
11. Guilleret I., Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 2003, 289:326-334.
12. Wu P., Meng L., Wang H., et al. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Biochem Biophys Res Commun 2005, 335:36-44.
13. Hajek M., Votruba I., Holy A., Krecmerova M., Tloust'Ova E. Alpha anomer of 5-aza-2'-deoxycytidine down-regulates hTERT mRNA expression in human leukemia HL-60 cells. Biochem Pharmacol 2008, 75:965-972.
14. Zhang D., Chen Y., Xie X., et al. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells. JMol Cell Cardiol 2012, 53:487-496.
15. Zhang D., Xie X., Chen Y., Hammock B.D., Kong W., Zhu Y. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium invitro and invivo. Circ Res 2012, 110:808-817.
16. Scalera F., Martens-Lobenhoffer J., Tager M., Bukowska A., Lendeckel U., Bode-Boger S.M. Effect of L-arginine on asymmetric dimethylarginine (ADMA) or homocysteine-accelerated endothelial cell aging. Biochem Biophys Res Commun 2006, 345:1075-1082.
17. Zhu J.H., Chen J.Z., Wang X.X., Xie X.D., Sun J., Zhang F.R. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. JMol Cell Cardiol 2006, 40:648-652.
18. Xu D., Neville R., Finkel T. Homocysteine accelerates endothelial cell senescence. Febs Lett 2000, 470:20-24.
19. Wang C.J., Hu C.P., Xu K.P., Tan G.S., Li Y.J. Effects of selaginellin on homocysteine-induced senescence in human umbilical vein endothelial cells. JCardiovasc Pharmacol 2010, 55:560-566.
20. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30:e47.
21. Ye S., Shaffer J.A., Kang M.S., et al. Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey). Am J Cardiol 2013, 111:962-967.
22. Takakura M., Kyo S., Inoue M., Wright W.E., Shay J.W. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 2005, 25:8037-8043.
23. Zhang D., Ai D., Tanaka H., Hammock B.D., Zhu Y. DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. Biochim Biophys Acta 2010, 1799:659-667.
24. Willeit P., Willeit J., Brandstatter A., et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2010, 30:1649-1656.
25. Spyridopoulos I., Hoffmann J., Aicher A., et al. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity. Circulation 2009, 120:1364-1372.
26. De Meyer T., Rietzschel E.R., De Buyzere M.L., et al. Systemic telomere length and preclinical atherosclerosis: the Asklepios Study. Eur Heart J 2009, 30:3074-3081.
27. Epel E.S., Blackburn E.H., Lin J., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004, 101:17312-17315.
28. Valdes A.M., Andrew T., Gardner J.P., et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
29. Armanios M., Blackburn E.H. The telomere syndromes. Nat Rev Genet 2012, 13:693-704.
30. Signorello M.G., Segantin A., Passalacqua M., Leoncini G. Homocysteine decreases platelet NO level via protein kinase C activation. Nitric Oxide 2009, 20:104-113.
31. Jamaluddin M.D., Chen I., Yang F., et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 2007, 110:3648-3655.
32. Meeran S.M., Patel S.N., Tollefsbol T.O. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 2010, 5:e11457.
33. Renaud S., Loukinov D., Abdullaev Z., et al. Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 2007, 35:1245-1256.
34. Horikawa I., Chiang Y.J., Patterson T., et al. Differential cis-regulation of human versus mouse TERT gene expression invivo: identification of a human-specific repressive element. Proc Natl Acad Sci U S A 2005, 102:18437-18442.
35. Ritz J.M., Kuhle O., Riethdorf S., et al. Anovel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues. Cancer Res 2005, 65:1187-1196.
36. Huzen J., Peeters W., de Boer R.A., et al. Circulating leukocyte and carotid atherosclerotic plaque telomere length: interrelation, association with plaque characteristics, and restenosis after endarterectomy. Arterioscler Thromb Vasc Biol 2011, 31:1219-1225.